ARCHIVES

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

This article is from The Cancer Letter archive.

Vol. 25 No. 33 | September 3, 1999

Download PDF Visit The Full Archive

Related Articles

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003

Advisors Urge NCI To Support Basic Chemoprevention.

January 7, 2000

DRCCA Board Votes To End Support For CCPDS July 31, 1983

May 14, 1982

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

April 25, 2013

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011